Monitor blood glucose in patients on long-term PPIs, say researchers

Regular use of proton pump inhibitors (PPIs) may increase the risk of developing type II diabetes, according to new research published in the journal Gut.

by Chloe Harman
Healthcare professionals should be aware of the potential risk of type II diabetes when prescribing PPIs, say researchers. | GETTY IMAGES
Healthcare professionals should be aware of the potential risk of type II diabetes when prescribing PPIs, say researchers. | GETTY IMAGES

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package